Letter to the Editor: Comment on "Utility of non-invasive liver fibrosis markers to predict the incidence of chronic kidney disease (CKD): A systematic review, meta-analysis, and meta-regression" by Supriyadi et al

Affiliations

¹ Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
² Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
³ Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China. Electronic address: jiangyong-612@163.com.

Comment

Zeyu Wang et al. Diabetes Metab Syndr. 2023 Nov.

. 2023 Nov;17(11):102879.

doi: 10.1016/j.dsx.2023.102879. Epub 2023 Oct 21.

¹ Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
² Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
³ Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China. Electronic address: jiangyong-612@163.com.

No abstract available

Keywords: Chronic kidney dysfunction; Fibrosis score; NAFLD.

Conflict of interest statement

Declaration of competing interest All authors declare no conflicts of interest that pertain to this work.

Utility of non-invasive liver fibrosis markers to predict the incidence of chronic kidney disease (CKD): A systematic review, meta-analysis, and meta-regression.
Supriyadi R, Yanto TA, Hariyanto TI, Suastika K. Supriyadi R, et al. Diabetes Metab Syndr. 2023 Aug;17(8):102814. doi: 10.1016/j.dsx.2023.102814. Epub 2023 Jun 20. Diabetes Metab Syndr. 2023. PMID: 37354810